Short-Acting GLP-1 RAs Linked With Increased Risk of GERD, Barret’s Esophagus
Patients with diabetes taking a GLP-1 RA of any type had an increased risk of a new GERD diagnosis.
Associations Between Anti-TNFα Exposure and Autoimmune Disease in IBD Patients
Anti-TNF agents were found to increase the risk of autoimmune disease, especially in psoriasis and lupus.
Cost Effectiveness of Vonoprazan to Manage Refractory Heartburn in Erosive Esophagitis
Vonoprazan appeared to be cost saving below a threshold price of $8.57 per pill.
Long COVID Risks, Symptoms Vary Among Diverse Populations
Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complex condition involving multiple organ systems.
Understanding User Needs is Critical for Developing Smoking Cessation Apps
Applications which utilize social media appear to reduce smoking relapse rates.
Assessing Barriers to Continuous Glucose Monitor Use in Patients With T1D, T2D
Device adoption among minority patients with type 1 and type 2 diabetes remains low due to socioeconomic disparities.
COVID-19: After the Emergency Ends
The COVID-19 public health emergency is over. What happens now?
Traveling With Daily Medications? Keep These Tips in Mind
A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.
Interventions Tailored to Race, Gender Could Help Decrease Drug Overdose Deaths
Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.
Stimulant Medications Not Associated With Substance Use Later in Life
Researchers hope a new study will alleviate patients and clinicians fear of prescribing stimulants for children with ADHD.
Anti-Inflammatory Drugs Prevented COVID-19 Deaths, But Didn’t Help Recovery Time
Fewer hospitalized patients with COVID-19 pneumonia died when treated with standard care plus either infliximab or abatacept.
FDA Approves First OTC Birth Control Pill in United States
The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.
Integrating Pharmacists Into a Collaborative Care Model Within Dermatology
Barriers that continue to exist include the challenges of recruiting exceptional pharmacists and the changing landscape of therapies for dermatologic conditions.
Pharmacist-Directed Weight Loss Service Can Help Patients in Ambulatory Care Clinics
The most frequently prescribed weight loss medication was semaglutide (Ozempic), followed by liraglutide (Saxenda), and dulaglutide (Trulicity).
Safety, Efficacy of Immune-Checkpoint Inhibitors in Patients With NSCLC And Chronic Hepatitis B
Immune-checkpoint inhibitors were comparably safe and effective in patients with chronic hepatitis B or occult hepatitis B infection.
Assessing Inhalation Technique in Uncontrolled Asthma, COPD Patients Using a Digihaler System
Electronic inhaler devices record objective inhalation quality data and permit assessment of patient efforts.
Sandoz Launches Action Plan to Increase Global Biosimilar Access
The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.
Generative AI Framework Could Help Create Better Medicine Faster
G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.
Can Simulation Training Help Pharmacists be More Prepared for Emergencies?
Over 90% of survey respondents said they believed emergency response simulation training should be required annually.
Optimizing Oncology Drug Interaction Alerts to Improve Patient Safety
Although excessive use can lead to fatigue, alerts can help proactively identify and prevent drug interactions.
Morning RX: June 9, 2023
Advisers with the FDA endorse a monoclonal antibody treatment for RSV in children, AstraZeneca and Quell sign a $2 billion agreement, and HSS hopes to strengthen the pediatric workforce.
Melanoma-Specific Survival Longer With Nivolumab Plus Relatlimab Combined Treatment
Nivolumab plus relatlimab showed a clear benefit in progression-free survival, overall survival and objective response rate.
Underrepresented Minority Patients Found to Have Altered Tumor Immune Microenvironment
Cytokine signaling pathways in sera from underrepresented minority patients were found to be enriched.
Exploring the Link Between Skin Self-Examination Performance and Melanoma Literacy
A survey found that only 24.6% of respondents have conducted a skin self-examination in the past 2 months.
Morning RX: June 8, 2023
A survey shows cancer centers are struggling, Google expands its generative AI into health care, and the WHO announces enhanced collaboration with the Global Fund.
Morning RX: June 7, 2023
Cue Health gets FDA’s first de novo approval for at-home COVID-19 test, Novavax says its new vaccine will fight new variants and HHS creates new cert standards for peer support workers.
Pharmacists Will Play Critical Role in Helping Patients Navigate Digital Therapeutics
With the rise of prescription digital therapeutics, pharmacists will need to prepare to manage the new paradigms of care.
Morning RX: June 6, 2023
Merck sues the federal government, the FDA will allow cancer drug imports from China, and a drug from GSK shows promise for endometrial cancer treatment.
Morning RX: June 5, 2023
Mandy Cohen is set to become the next CDC director, Medicare will cover a new class of Alzheimer’s drugs, and the WHO announces a landmark digital health initiative.
Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID
New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.
2 Clarke Drive Cranbury, NJ 08512